GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Huons Global Co Ltd (XKRX:084110) » Definitions » Price-to-Owner-Earnings

Huons Global Co (XKRX:084110) Price-to-Owner-Earnings : 45.97 (As of Jun. 09, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Huons Global Co Price-to-Owner-Earnings?

As of today (2024-06-09), Huons Global Co's share price is ₩23450.00. Huons Global Co's Owner Earnings per Share (TTM) ended in Mar. 2024 was ₩510.06. It's Price-to-Owner-Earnings for today is 45.97.


The historical rank and industry rank for Huons Global Co's Price-to-Owner-Earnings or its related term are showing as below:

XKRX:084110' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 0.48   Med: 25.37   Max: 4911.83
Current: 45.98

During the past 13 years, the highest Price-to-Owner-Earnings of Huons Global Co was 4911.83. The lowest was 0.48. And the median was 25.37.


XKRX:084110's Price-to-Owner-Earnings is ranked worse than
74.7% of 423 companies
in the Drug Manufacturers industry
Industry Median: 25.31 vs XKRX:084110: 45.98

As of today (2024-06-09), Huons Global Co's share price is ₩23450.00. Huons Global Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₩4,707.00. Therefore, Huons Global Co's PE Ratio for today is 4.98.

As of today (2024-06-09), Huons Global Co's share price is ₩23450.00. Huons Global Co's EPS without NRI for the trailing twelve months (TTM) ended in was ₩4,462.92. Therefore, Huons Global Co's PE Ratio without NRI for today is 5.25.

During the past 13 years, Huons Global Co's highest PE Ratio without NRI was 6720.00. The lowest was 4.67. And the median was 23.37.


Huons Global Co Price-to-Owner-Earnings Historical Data

The historical data trend for Huons Global Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huons Global Co Price-to-Owner-Earnings Chart

Huons Global Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.27 7.73 - - -

Huons Global Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 45.00

Competitive Comparison of Huons Global Co's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Huons Global Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Huons Global Co's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Huons Global Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Huons Global Co's Price-to-Owner-Earnings falls into.



Huons Global Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Huons Global Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=23450.00/510.06
=45.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Huons Global Co  (XKRX:084110) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Huons Global Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Huons Global Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Huons Global Co (XKRX:084110) Business Description

Traded in Other Exchanges
N/A
Address
901, Pangyo Innovalley C, 621, Sampyeong-dong Bundang-gu, Gyeonggi-do, KOR, 153-788
Huons Global Co Ltd is active in the healthcare sector. Its primary business includes the manufacture and sale of pharmaceutical products. The company functions through three divisions; pharmaceuticals, medical devices, and cosmetics. The pharmaceutical division represents the production of ethical drugs like the local anesthetic. The medical devices division is engaged in developing devices to aid safe preparation of platelet-poor plasma and platelet concentrate from the sample of blood. The company's suite of cosmetic products comprises of cleansers, creams, and sunscreens.

Huons Global Co (XKRX:084110) Headlines

No Headlines